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The 1,995,275-bp genome of Coxiella burnetii, Nine Mile phase I
RSA493, a highly virulent zoonotic pathogen and category B
bioterrorism agent, was sequenced by the random shotgun
method. This bacterium is an obligate intracellular acidophile that
is highly adapted for life within the eukaryotic phagolysosome.
Genome analysis revealed many genes with potential roles in
adhesion, invasion, intracellular trafficking, host-cell modulation,
and detoxification. A previously uncharacterized 13-member fam-
ily of ankyrin repeat-containing proteins is implicated in the
pathogenesis of this organism. Although the lifestyle and parasitic
strategies of C. burnetii resemble that of Rickettsiae and Chlamyd-
iae, their genome architectures differ considerably in terms of
presence of mobile elements, extent of genome reduction, meta-
bolic capabilities, and transporter profiles. The presence of 83
pseudogenes displays an ongoing process of gene degradation.
Unlike other obligate intracellular bacteria, 32 insertion sequences
are found dispersed in the chromosome, indicating some plasticity
in the C. burnetii genome. These analyses suggest that the obligate
intracellular lifestyle of C. burnetii may be a relatively recent
innovation.
Coxiella burnetii, the etiological agent of ‘‘Q fever,’’ is acategory B bioterrorism agent that is highly infective to both
humans and livestock (1). In humans, the disease manifests as an
acute flu-like illness, with a hallmark debilitating headache and
cyclic fever (1). Instances of chronic disease are characterized by
endocarditis (1). A correlation has been suggested between C.
burnetii infections and onset of atherosclerosis, chronic-fatigue
syndrome, and other cerebrovascular incidents (2, 3). In live-
stock, abortion epidemics have been reported in endemic regions
resulting in severe economic impacts (4, 5).
C. burnetii is an obligate intracellular, Gram-negative acido-
phile that replicates to high numbers, albeit with an estimated
slow doubling time (12–20 h) (6), within the phagolysosome (PL)
of the eukaryotic phagocyte (7). It is highly adapted to thrive
within this compartment where low pH (4.5), hydrolytic en-
zymes, oxygen and nitrogen radicals, and other stresses typically
result in microbial killing. C. burnetii is capable of survival
outside the host for extended periods of time; high-level resis-
tance to UV radiation, heat, desiccation, pressure [50,000 psi
(1 psi  6.89 kPa)], and osmotic and oxidative stress has been
demonstrated (8). Some of this resistance has been attributed to
its biphasic (asynchronous) developmental cycle involving dis-
tinct morphological variants (9). A tick host (Dermacentor
andersonii) has been implicated in transmission between various
vertebrate hosts (10). Ease of aerosol dissemination, environ-
mental persistence, and high infectivity (ID50 1–10) (11) make
C. burnetii a serious threat for military personnel and civilians.
This agent has already been weaponized and mass-produced
under various biological warfare programs (12). Because the
lifestyle of the pathogen causes it to be largely intractable to
study by using contemporary molecular-genetic methods, the
genome sequence contributes significantly to our understanding
of the biology and pathogenesis of C. burnetii, additionally
serving as a comparative paradigm to study the evolution of
obligate intracellular parasitism.
Methods
Sequencing. The genome of C. burnetii Nine Mile phase I
RSA493, a tick isolate identified in 1935 (10), was sequenced and
assembled by using the random shotgun method (13). Circular
topography of the chromosome was confirmed by examining
clone coverage in the region where a break was predicted (14)
and validated by GC skew.
Coding Sequence (CDS) Prediction and Gene Identification. ORFs
likely to encode proteins (CDSs) were predicted by GLIMMER
(15). All predicted proteins larger than 30 aa were searched
against a nonredundant protein database (13). Frameshifts and
point mutations were detected and corrected where appropriate.
Remaining frameshifts and point mutations are considered to be
authentic and were annotated as ‘‘authentic frameshift’’ or
‘‘authentic point mutation.’’ Protein membrane-spanning do-
mains were identified by TOPPRED (16, 17). Putative signal
peptides were identified with SIGNALP (17). The 5 regions of
each CDS were inspected to define initiation codons using
homologies, position of ribosomal binding sites, and transcrip-
tional terminators. Two sets of hidden Markov models were used
to determine CDS membership in families and superfamilies:
PFAM 5.5 (18) and TIGRFAM (19). PFAM 5.5 hidden Markov models
were also used with a constraint of a minimum of two hits to find
repeated domains within proteins and mask them. Domain-
based paralogous families were built by performing all-versus-all
searches on the remaining protein sequences. Base pair one was
assigned within the putative origin of replication determined by
colocalization of genes (dnaA, dnaN, recF, and gyrA) often found
near the origin in prokaryotic genomes and GC nucleotide
skew (G  CG  C) analysis (20). All CDSs were searched
with FASTA3 against all CDSs from the complete genomes,
Abbreviations: PL, phagolysosome; CDS, coding sequence; IS, insertion sequence.
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and matches with a FASTA3 P value of 105 were considered
significant.
Trinucleotide Composition. Distribution of all 64 trinucleotides
(3-mers) for each chromosome was determined, and the 3-mer
distribution in 2,000-bp windows that overlapped by half their
length (1,000 bp) across the genome was computed. For each
window, we computed the 2 statistic on the difference between
its 3-mer content and that of the whole chromosome. A large
value for 2 indicates that the 3-mer composition in this window
is different from the rest of the chromosome. Probability values
for this analysis are based on assumptions that the DNA
composition is relatively uniform throughout the genome and
that 3-mer composition is independent. Because these assump-
tions may be incorrect, we prefer to interpret high 2 values as
indicators of regions on the chromosome that appear unusual
and demand further scrutiny.
Results and Discussion
General Features of the Genome. General features of the
1,995,275-bp chromosome and 37,393-bp previously sequenced
QpH1 plasmid (21) of C. burnetii Nine Mile phase I are
summarized in Table 1. Although previously suspected to be
linear (14), genome sequencing and analysis suggest a circular
topology for the chromosome (see Methods). The genome is
predicted to encode 2,134 CDSs, of which 719 (33.7%) are
hypothetical, i.e., have no significant matches to other sequenced
genes, which is a high proportion given the large number of
-proteobacterial genome sequences currently available.
Although Coxiella was historically considered ‘‘Rickettsia-
like,’’ 16S rRNA gene sequence analysis (22) and genome
analysis (based on shared proteins across genomes and phylo-
genetic analysis of a set of 20 highly conserved proteins) indicate
that it is a -proteobacteria (order Legionellales) and thus is
distant from the -proteobacterial Rickettsia group. Coxiella is
also distant from any other lineage within the  subgroup, its
closest relationship is with Legionella pneumophila, a facultative
intracellular human pathogen, and Rickettsiella grylli, an intra-
cellular arthropod pathogen (23).
Various intervening elements have been identified within
physiologically vital genes of C. burnetii. A putative excisable
intein is located in the C-terminal region of the replicative DNA
helicase (CBU0868), and the sole 23S rRNA gene is interrupted
both by an intervening sequence (24) and a group I self-splicing
intron (Fig. 1a). The mechanism of excision of these two
elements in the 23S rRNA is very different; the intervening
sequence is excised from the RNA without exon ligation, result-
ing in a fragmented but functional rRNA (24), whereas the
intron is presumed to splice out precisely, resulting in no further
fragmentation. The intron encodes a LAGLIDADG homing
endonuclease that may play a role in intron mobility (25). This
endonuclease is most similar to rRNA-associated intron endo-
nucleases found in organelle genomes of single-celled eu-
karyotes (Fig. 1b); however, members of this endonuclease
family are not found in most other prokaryotic genomes or
nuclear genomes of eukaryotes. Although it is possible that a
common ancestor of C. burnetii (-proteobacteria), mitochon-
dria (-proteobacteria), and plastids (cyanobacteria) encoded
this endonuclease and this gene was subsequently lost in numer-
ous other lineages, it is more likely that some of these lineages
acquired the gene by lateral gene transfer. Because the endo-
nuclease is associated with a mobile element, its lateral transfer
seems likely, but the exact mechanism for the transfer (i.e., what
the donor and recipient lineages were) is not possible to infer
with the available data.
Comparative Analysis of Obligate Intracellular Pathogens. Obligate
intracellular pathogens (i.e., Rickettsia, Chlamydia, and Myco-
bacterium leprae) appear to share characteristics such as reduced
metabolic and transport capabilities and lack of mobile elements.
Although C. burnetii ostensibly shares similarities in lifestyle and
parasitic strategies with these bacteria, the genome differs
considerably, particularly in terms of presence of mobile ele-
ments, extent of genome reduction, metabolic capabilities, and
transporter profiles. However, C. burnetii does occupy a different
intracellular niche compared with these other bacteria, and
substrates or nutrients in the PL may be quite different from
those encountered in other compartments.
Insertion sequences (ISs). Genomes of other obligate intracellular
bacteria have few to no IS elements (26–29), presumably because
of limited opportunities for gene transfer. By contrast, C. burnetii
possesses 29 IS elements; there are 21 copies of a unique
Table 1. General features of the C. burnetii genome
Chromosome QpH1
Size, bp 1,995,275 37,393
G  C content, % 42.6 39.3
Protein-coding genes
No. similar to known proteins 1,022 11
No. similar to proteins of unknown function* 179 5
No. of conserved hypotheticals† 200 1
No. of hypotheticals‡ 693 23
Total 2,094 40
Average ORF size, bp 849 736
Coding, % 89.1 78.8
Stable RNAs
rRNA 3 0
tRNA 42 0
*Unknown function and significant sequence similarity to a named protein for
which no function is currently attributed.
†Conserved hypothetical protein with sequence similarity to a translation of
another ORF; however, no experimental evidence for protein expression
exists.
‡Hypothetical protein with no significant similarity to any other sequenced
protein.
Fig. 1. (a) Schematic representation of the 5S-23S-16S components of the
rRNA operon in C. burnetii. The intervening sequences (IVSs) located in the 23S
rRNA gene are indicated. (b) Phylogenetic clustering of the C. burnetii group
I intron endonuclease with other sequenced endonucleases. Amino acid se-
quences were aligned by using CLUSTALW, and a neighbor-joining tree was
generated from the alignment by using the PAUP program. All nodes had
bootstrap values 85%. The C. burnetii endonuclease clusters with intron-
associated endonucleases from the mitochondrial genomes of Monomastix
spp., Acanthamoeba castellani, and other single-celled eukaryote mitochon-
drial and chloroplast genomes.
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IS110-related isotype, IS1111 (30), 5 IS30 and 3 ISAs1 family
elements, and 3 degenerate transposase genes of unknown
lineage. The transposase genes are 99% identical in DNA
sequence within each group, suggesting either recent introduc-
tion and spread of each IS element or homogenization by
concerted evolution as occurs with rRNA genes (31).
In C. burnetii the IS elements are dispersed around the
chromosome (but not found on the plasmid), and there is no
localized clustering. Although there is little evidence of recently
acquired DNA in the genome (Fig. 2; see Methods), in one case
identical elements flank groups of genes in a manner reminiscent
of ‘‘pathogenicity islands’’ (32). This potential island is f lanked
by IS1111 elements (CBU1218 and CBU1186), found adjacent to
tRNA-serine genes. The region includes a putative multidrug
transporter protein (CBU1208), a sterol reductase (CBU1206),
and numerous hypothetical proteins.
Genome reduction in C. burnetii: A work in progress? Genome analysis
identified 83 ‘‘pseudogenes’’ (genes disrupted by one or more
authentic frameshifts andor point mutations or, in some cases,
truncations) suggesting that some genome reduction is under-
way. Reductive evolution has been found to be common in
obligate intracellular bacteria. During genome reduction, genes
that once had an important function accumulate mutations and
eventually disappear either because they are no longer under
strong selective pressures (e.g., if the niche of the organism has
changed) or because of population-level phenomena that lead to
an inability to maintain genes under weak selection (e.g., Mul-
ler’s ratchet) (33). Because many of the pseudogenes are dis-
rupted by a single frameshift, it would seem that they are of
recent origin [as suggested for Salmonella typhimurium (34)].
Additionally, a much higher percentage of the C. burnetii
genome is coding (89.1%) than for species known to have
undergone large amounts of genome reduction (76% in both
Rickettsia prowazekii and M. leprae), suggesting that either the
reduction process has just begun in C. burnetii or it may not be
as severe in this species as in some others.
Pseudogenes are overrepresented in specific role categories
(e.g., toxin production and resistance, transport and binding,
conserved hypothetical, and unknown function) suggesting elim-
ination of functions no longer relevant to the lifestyle. For
example, components of a competence system (for uptake of
extracellular DNA), ComA (CBU0855), ComF (CBU0464), and
ComM (CBU2022), possess one or more frameshifts; suggesting
C. burnetii may not be naturally competent, although putative
ComE (CBU0532) and ComL (CBU0758) genes are intact.
Several homologues of Bacillus spp. peptide synthetases (for
nonribosomal synthesis of antimicrobial lantibiotics) are highly
degenerate (Table 2, which is published as supporting informa-
tion on the PNAS web site, www.pnas.org). Frameshifts are also
detected in predicted -lactamases that confer resistance to
-lactams (Table 2). The C. burnetii Nine Mile isolate is not
described as being naturally resistant to antibiotics; in fact this
strain is considered to be highly susceptible to various antibiotics
relative to some chronic disease-causing isolates (35).
Transport and Metabolism. The transporter content of C. burnetii
seems to largely reflect its intracellular lifestyle within the hostile
environment of the PL. Four predicted sodium ionproton
exchangers (CBU1590, CBU1259, CBU0459, and CBU1582–
CBU1588) probably play an important role in pH homeostasis
and survival within the acidic PL. Three predicted mechanosen-
sitive ion channels and three transporters for osmoprotectants
might provide resistance to osmotic stress. More than a quarter
of the transporters in C. burnetii are predicted drug-eff lux
systems, a higher proportion than seen in other proteobacteria
(Fig. 5, which is published as supporting information on the
PNAS web site). One possible role of these predicted drug-eff lux
pumps is to provide resistance to host-produced antimicrobial
defensins within the PL. Alternately, they may have had a role
in secondary metabolite secretion, because several polyketide
biosynthesis genes are encoded on the C. burnetii genome;
however, many of them are pseudogenes (Table 2).
C. burnetii possesses greater transport capabilities for organic
nutrients than Chlamydia and Rickettsia; however, these capabilities
are limited compared with those of free-living bacteria. Only two
sugar transport systems were identified: proton-driven systems for
xylose (CBU0347) and glucose (CBU0265). Histidine phosphocar-
rier protein (HPr) and enzyme I of the sugar phosphotransferase
system are present, as is HPr serine kinase, but no phosphotrans-
ferase system transporters were detected; thus these Hpr proteins
presumably play only a regulatory role. The presence of 15 trans-
porters for amino acids and 3 for peptides suggest that these may
be the dominant carbon sources for C. burnetii, reflecting their
abundance within the PL. Biochemical studies of C. burnetii have
focused on glutamate utilization (36), and genome analysis allowed
identification of a probable glutamate uptake transporter
(CBU2020). Unlike rickettsial and chlamydial species, C. burnetii
does not possess any ATPADP exchangers that enable these
organisms to function as energy parasites by scavenging ATP from
their host (37), confirming previous experimental observations
(38). There are six transporters of unknown specificity belonging to
a previously uncharacterized subfamily of the major facilitator
superfamily, which seem to have undergone amplification in the
C. burnetii lineage.
C. burnetii has greater biosynthetic capabilities in contrast to
obligate intracellular bacteria that have reduced metabolic ca-
Fig. 2. Circular representation of the C. burnetii RSA493 overall genome
structure. The outer scale designates coordinates in base pairs. The first circle
shows predicted coding regions on the plus strand color-coded by role cate-
gories: violet, amino acid biosynthesis; light blue, biosynthesis of cofactors,
prosthetic groups, and carriers; light green, cell envelope; red, cellular pro-
cesses; brown, central intermediary metabolism; yellow, DNA metabolism;
light gray, energy metabolism; magenta, fatty acid and phospholipid metab-
olism; pink, protein synthesis and fate; orange, purines, pyrimidines, nucleo-
sides, and nucleotides; olive, regulatory functions and signal transduction;
dark green, transcription; teal, transport and binding proteins; gray, unknown
function; salmon, other categories; blue, hypothetical proteins. The second
circle shows predicted coding regions on the minus strand color-coded by role
categories: third circle, pseudogenes in green; fourth circle, IS elements in red;
fifth circle, tRNA genes in violet; sixth circle, rRNA genes in dark brown;
seventh circle, trinucleotide composition in black; eighth circle, GC-skew curve
in blue (positive residues) and gray (negative residues).
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pability as a result of increased dependence on host-derived
substrates (39). C. burnetii possesses enzymes for glycolysis, the
Entner–Doudoroff pathway, the electron transport chain, the
Embden–Meyerhof–Parnas pathway, gluconeogenesis, the pen-
tose phosphate pathway, and the tricarboxylic acid (TCA) cycle.
The glyoxylate bypass is absent, probably because C. burnetii is
largely reliant on exogenously acquired amino acids and does not
need to recharge the TCA cycle by synthesizing intermediates for
amino acid synthesis. Additionally, exogenous amino acids can
also be degraded to TCA intermediates when needed. Pathways
for synthesis of purine and pyrimidines, fatty acids and phos-
pholipids, and cofactors (biotin, ubiquinone, and folic acid) are
also intact. Most components of a mevalonate pathway
(CBU0607–CBU0609) for the synthesis of isopentyl diphosphate
(IPP) or isoprenoids (except a HMG-CoA synthase) were iden-
tified. The glyceraldehyde-3-phosphate (GAP) pyruvate path-
way for IPP synthesis seen in most Gram-negative bacteria is
absent, which suggests that C. burnetii may synthesize IPP solely
via a mevalonate pathway characteristic of Gram-positive bac-
teria and Archaea. The anabolic capabilities of C. burnetii are not
comprehensive; it is predicted to be an auxotroph for 11 amino
acids. Some of these biosynthetic pathways are absent in their
entirety, whereas others are missing key enzymatic members.
The presence of amino acid transporters probably compensates
for these deficiencies, enabling acquisition of amino acids from
the host.
Reductive convergent evolution of Coxiella, Chlamydia spp.,
and Rickettsia spp. is suggested by shared absences of enzymatic
steps for tryptophan and lysine biosynthesis. Similar to Rickettsia
and Chlamydia, C. burnetii encodes all steps for the lysine
biosynthesis pathway except the terminal step involving diamin-
opimelate decarboxylase (CBU1030 is degraded), suggesting
that diaminopimelate synthesis is the primary function and that
C. burnetii is a lysine auxotroph. The tryptophan biosynthesis
operon is unusual; TrpA, -C, and -E (CBU1156, CBU1154, and
CBU1152) are intact, phosphoribosyl anthranilate isomerase
(TrpF) and tryptophan synthase (TrpB) are fused (CBU1155),
and anthranilate phosphoribosyl transferase (TrpDG) has mul-
tiple frameshifts (CBU1153). This disrupts the initial two steps
of the pathway (from chorsimate to phosphoribosyl anthrani-
late); however, the presence of subsequentterminal steps sug-
gests that tryptophan can be synthesized from intermediates
taken up from the host as seen in Chlamydiae (40, 41). Chla-
mydial acquisition of host-derived intermediates (released from
protective IFN--induced tryptophan degradation) and subse-
quent recycling to tryptophan is considered an adaptive viru-
lence strategy (40).
Genome analysis reveals pathways for the utilization of few
sugars (glucose, galactose, and xylose) and glycerol (however, no
transporter for glycerol uptake is identified). Contents of the
parasitophorous vacuole are undefined; however, the PL is
typically known to contain many enzymes for degradation of
polysaccharides (42), and therefore free sugars may be plentiful
in this environment. Given the ability of C. burnetii to persist in
the extracellular environment for prolonged periods, the absence
of pathways for synthesis of storage compounds such as glycogen,
trehalose, or polyhydroxybutyrate is unexpected. Although
genes for synthesis of lipid A and 2-keto-3-deoxyoctulosonic acid
components of the lipopolysaccharide are scattered, genes for
the synthesis of lipopolysaccharide core and outer repeating
units of the O-antigen are clustered into two regions (at coor-
dinates 612,249–642,009 and 779,513–806,121). These regions
contain a large number of genes pertaining to nucleotide sugar
metabolism (e.g., dehydratases, dehydrogenases, epimerases,
and reductases) involved in polymerization of sugars in the
O-antigen chains. Also found in the region are candidates
(CBU0691 and CBU0683) for synthesizing two unusual sugars
present in the Coxiella lipopolysaccharide [6-deoxy-3-C-
methylgulose or virenose and 3-C-(hydroxymethyl)-lyxose] (43)
by methylation of pyranose and furanose nucleotide sugars,
similar to pathways for macrolide and other antibiotic synthesis.
C. burnetii encodes a number of genes that are similar to
eukaryotic genes and have no matches to any sequenced pro-
karyotic genes, for example, a eukaryotic fatty acid desaturase
(CBU0920) homologue that may play a role in synthesis of
diverse saturated and unsaturated fatty acids and two sterol
reductases (CBU1206 and CBU1158) involved in cholesterol
synthesis in eukaryotes. The absence of other related enzymes
suggests that de novo synthesis of cholesterol is unlikely. It is
more likely that these sterol reductases play a role in conversion
of metabolites taken up from the host and possibly even con-
tribute to the tissue- or organotropisms (placenta and reproduc-
tive tissue) attributed to this organism (1, 44). A correlation
between hormonal levels of pregnant animals and increased C.
burnetii infection has also been suggested (45, 46).
Pathogenesis. Adhesion and invasion are critical early events that
determine successful colonization. Although C. burnetii lacks genes
encoding typical structures for adhesion (e.g., pili and other ad-
hesins), it possesses 13 ankyrin repeat-containing proteins that may
be implicated in host-cell attachment (Table 3, which is published
as supporting information on the PNAS web site). Ankyrins are
spectrin-binding proteins that mediate interaction of the membrane
skeleton with the plasma membrane (47). However, ankyrin
domains have also been identified in some transcriptional regula-
tors that may play a role in altering host-cell gene expression as
suggested for Ehrlichia spp. (48). Although ankyrin domains are not
unique to C. burnetii, the presence of 13 proteins with this domain
is higher than in any other sequenced genome. Although bacterial
ligands and host-cell receptors that mediate internalization have not
been identified previously, entry via v3 integrin or CR3 comple-
ment receptor has been suggested (49). Genome analysis identified
Fig. 3. (a) Average and median pI values of all predicted proteins for C.
burnetii and a subset of sequenced -proteobacteria and intracellular bacte-
rial genomes. (b) Percentage of total proteins in given pI ranges for C. burnetii
and various sequenced bacterial genomes.
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several CDSs with the integrin-binding RGD motif and signal
sequence that may be candidates for facilitating internalization
(Table 3). Additionally, C. burnetii contains homologues of L.
pneumophila EnhA (CBU1122 and CBU1138), EnhB (CBU1137
and CBU0053), and EnhC (CBU1136) genes that have been
implicated in an enhanced cell-entry phenotype (50) and may
interact with the host; signal peptides are predicted for all. Cy-
toskeletal rearrangements have been suggested to play a critical role
in internalization of C. burnetii (51). These rearrangements may be
mediated by a tyrosine-phosphorylated GTPase regulator
(CBU0884) analogous to BipA of enteropathogenic Escherichia
coli that triggers cytoskeletal rearrangements (52).
Modification of host-cell proteins by intracellular pathogens is
an important virulence strategy. A putative eukaryotic-type
protein kinase (CBU1379) and an acid phosphatase (CBU0335)
may play a role in modulation of host response. Phosphorylation
of host proteins by C. burnetii acid phosphatase activity results
in diminished oxidative burst after phagocytosis (53).
Although other intracellular pathogens typically evade
phagolysosomal fusion, C. burnetii targets this prohibitive niche
where it is under considerable oxidative and osmotic stress (8).
A number of genes associated with stress-response or vacuole
detoxification systems are present (Table 3). Protection against
low pH may be conferred by basic proteins that could serve as
a proton ‘‘sink’’ to buffer against the excess protons that may
enter the bacterial cell from the acidic environment of the PL
(54). C. burnetii encodes an unusually high number of basic
proteins; the average pI value for all predicted proteins is 8.25,
which is higher than for most other sequenced genomes, with the
exception of Helicobacter pylori, which resides in the low-pH
environment of the gastric mucosa (Fig. 3a). Furthermore,
45% of C. burnetii proteins were found to have a pI value of
9, in striking contrast to the proteome of other -proteobac-
teria and intracellular pathogens (Fig. 3b).
Active secretion of proteins into host cells by intracellular
pathogens is often implicated in intracellular trafficking and
virulence (55). Genome analysis revealed components of types
I- II, and IV secretion systems (Table 3). The type IV secretion
system is related to that of L. pneumophila, of which three
components (IcmKST) were identified previously (56). Analysis
of this region reveals a number of inversions, insertions,
and deletions in C. burnetii relative to the gene organization in
L. pneumophila (Fig. 4). The IS1111 transposase located in this
cluster may be responsible for part of the rearrangements. An
IcmF homologue (CBU0320) is located elsewhere and possesses
a point mutation. No homologues of IcmM and IcmR or of the
few described type IV effectors are seen; however, the hypo-
thetical genes identified within this cluster or flanking it may be
candidates.
Conclusion
Because the lifestyle of C. burnetii causes it to be largely
refractory to study with contemporary molecular-genetic meth-
ods, the genome sequence has contributed significantly to our
understanding of the biology and pathogenesis of this organism.
Previously uncharacterized genes implicated in adhesion, inva-
sion, intracellular trafficking, host modulation, detoxification,
and other virulence-related functions have been identified. The
relatively high proportion of hypothetical genes may be involved
in functions relevant to the unique developmental cycle and
lifestyle of C. burnetii. Genome analysis has revealed the pres-
ence of numerous mobile elements and pseudogenes, indicating
plasticity and ongoing genome reduction. These observations
and comparisons to genomes of other sequenced obligate intra-
cellular bacteria suggest that C. burnetii may have transitioned
relatively recently into its current lifestyle.
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Fig. 4. Linear representation of the locus encoding a putative type IV
secretion system in C. burnetii with relation to L. pneumophila icm-dot genes.
Genes are shown as arrowheads and colored by predicted function: orange,
putative type IV secretion system components; black, hypothetical protein;
gray, conserved hypothetical protein; red, IS1111 element transposase. Black
lines connect genes with best matches to L. pneumophila genes (shown in
white) at a P-value cutoff of 105. Both CBU1629 and CBU1630 show
significant similarity to IcmL; however, they are not identical to each other.
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